APA (7th ed.) Citation

Ozgol, I., Yigit Gencer, E., Yildiz, C., Karabulut, D., Turhan Çaglar, F. N., Bicakhan, B., . . . Yigit, Z. (2025). Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature. Journal of Clinical Medicine, 14(20), 7395. https://doi.org/10.3390/jcm14207395

Chicago Style (17th ed.) Citation

Ozgol, Ilhan, et al. "Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature." Journal of Clinical Medicine 14, no. 20 (2025): 7395. https://doi.org/10.3390/jcm14207395.

MLA (9th ed.) Citation

Ozgol, Ilhan, et al. "Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature." Journal of Clinical Medicine, vol. 14, no. 20, 2025, p. 7395, https://doi.org/10.3390/jcm14207395.